Adenovirus-mediated overexpression of human tissue plasminogen activator prevents peritoneal adhesion formation/reformation in rats

Surgery

Volumn 146, Issue 1, 2009, Pages 12-17

  Atta, Hussein M ^a   Al Hendy, Ayman ^a   El Rehany, Mahmoud A ^b   Dewerchin, Mieke ^c   Abdel Raheim, Salama R ^b   Ghany, Hend Abdel ^b   Fouad, Rasha ^b  

^a Minia University   (Egypt)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^c Vesalius Research Center   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; MESSENGER RNA; PHOSPHATE BUFFERED SALINE; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE PLASMINOGEN ACTIVATOR; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHEMICAL ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; DRUG EFFECT; DRUG SAFETY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE OVEREXPRESSION; MALE; NONHUMAN; PERITONEUM ADHESION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCORING SYSTEM; VIRAL GENE THERAPY;

ADENOVIRIDAE; ANIMALS; DISEASE MODELS, ANIMAL; FIBRINOLYSIS; HUMANS; INJECTIONS, INTRAPERITONEAL; MALE; PERITONEAL DISEASES; RATS; RATS, WISTAR; SEVERITY OF ILLNESS INDEX; TISSUE ADHESIONS; TISSUE PLASMINOGEN ACTIVATOR; TRANSFECTION;

EID: 67249164542     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2009.02.018     Document Type: Article

References (25)

1. Liakakos T., Thomakos N., Fine P.M., Dervenis C., and Young R.L. Peritoneal adhesions: etiology, pathophysiology, and clinical significance. Recent advances in prevention and management. Dig Surg 18 (2001) 260-273
2. Ellis H., Moran B.J., Thompson J.N., Parker M.C., Wilson M.S., Menzies D., et al. Adhesion-related hospital readmissions after abdominal and pelvic surgery: a retrospective cohort study. Lancet 353 (1999) 1476-1480
3. Ray N.F., Denton W.G., Thamer M., Henderson S.C., and Perry S. Abdominal adhesiolysis: inpatient care and expenditures in the United States in 1994. J Am Coll Surg 186 (1998) 1-9
4. Ray N.F., Larsen Jr. J.W., Stillman R.J., and Jacobs R.J. Economic impact of hospitalizations for lower abdominal adhesiolysis in the United States in 1988. Surg Gynecol Obstet 176 (1993) 271-276
5. Wallwiener M., Brucker S., Hierlemann H., Brochhausen C., Solomayer E., and Wallwiener C. Innovative barriers for peritoneal adhesion prevention: liquid or solid? A rat uterine horn model. Fertil Steril 86 (2006) 1266-1276
6. Yeo Y., Ito T., Bellas E., Highley C.B., Marini R., and Kohane D.S. In situ cross-linkable hyaluronan hydrogels containing polymeric nanoparticles for preventing postsurgical adhesions. Ann Surg 245 (2007) 819-824
7. Wallwiener D., Meyer A., and Bastert G. Adhesion formation of the parietal and visceral peritoneum: an explanation for the controversy on the use of autologous and alloplastic barriers?. Fertil Steril 69 (1998) 132-137
8. Cohen Z., Senagore A.J., Dayton M.T., Koruda M.J., Beck D.E., Wolff B.G., et al. Prevention of postoperative abdominal adhesions by a novel, glycerol/sodium hyaluronate/carboxymethylcellulose-based bioresorbable membrane: a prospective, randomized, evaluator-blinded multicenter study. Dis Colon Rectum 48 (2005) 1130-1139
9. Doody K.J., Dunn R.C., and Buttram Jr. V.C. Recombinant tissue plasminogen activator reduces adhesion formation in a rabbit uterine horn model. Fertil Steril 51 (1989) 509-512
10. Hellebrekers B.W., Trimbos-Kemper T.C., Trimbos J.B., Emeis J.J., and Kooistra T. Use of fibrinolytic agents in the prevention of postoperative adhesion formation. Fertil Steril 74 (2000) 203-212
11. Buckenmaier III C.C., Summers M.A., and Hetz S.P. Effect of the antiadhesive treatments, carboxymethylcellulose combined with recombinant tissue plasminogen activator and Seprafilm, on bowel anastomosis in the rat. Am Surg 66 (2000) 1041-1045
12. Menzies D., and Ellis H. The role of plasminogen activator in adhesion prevention. Surg Gynecol Obstet 172 (1991) 362-366
13. Vipond MN, Whawell SA, Scott-Coombes DM, Thompson JN, Dudley HA. Experimental adhesion prophylaxis with recombinant tissue plasminogen activator. Ann R Coll Surg Engl 19194;76:412-5.
14. Hellebrekers B.W., Trimbos-Kemper T.C., Boesten L., Jansen F.W., Kolkman W., Trimbos J.B., et al. Preoperative predictors of postsurgical adhesion formation and the prevention of adhesions with plasminogen activator (PAPA-study): results of a clinical pilot study. Fertil Steril 91 (2009) 1204-1214
15. Orita H., Fukasawa M., Girgis W., and diZerega G.S. Inhibition of postsurgical adhesions in a standardized rabbit model: intraperitoneal treatment with tissue plasminogen activator. Int J Fertil 36 (1991) 172-177
16. Montz F.J., Fowler J.M., Wolff A.J., Lacey S.M., and Mohler M. The ability of recombinant tissue plasminogen activator to inhibit post-radical pelvic surgery adhesions in the dog model. Am J Obstet Gynecol 165 (1991) 1539-1542
17. Carmeliet P., Stassen J.M., Van V.I., Meidell R.S., Collen D., and Gerard R.D. Adenovirus-mediated transfer of tissue-type plasminogen activator augments thrombolysis in tissue-type plasminogen activator-deficient and plasminogen activator inhibitor-1-overexpressing mice. Blood 90 (1997) 1527-1534
18. Al-Hendy A., Magliocco A.M., Al-Tweigeri T., Braileanu G., Crellin N., Li H., et al. Ovarian cancer gene therapy: repeated treatment with thymidine kinase in an adenovirus vector and ganciclovir improves survival in a novel immunocompetent murine model. Am J Obstet Gynecol 182 (2000) 553-559
19. Rodgers K., Cohn D., Hotovely A., Pines E., Diamond M.P., and diZerega G. Evaluation of polyethylene glycol/polylactic acid films in the prevention of adhesions in the rabbit adhesion formation and reformation sidewall models. Fertil Steril 69 (1998) 403-408
20. Holmdahl L., Eriksson E., Eriksson B.I., and Risberg B. Depression of peritoneal fibrinolysis during operation is a local response to trauma. Surgery 123 (1998) 539-544
21. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J Biol Chem 193 (1951) 265-275
22. Saed G.M., and Diamond M.P. Modulation of the expression of tissue plasminogen activator and its inhibitor by hypoxia in human peritoneal and adhesion fibroblasts. Fertil Steril 79 (2003) 164-168
23. Hellebrekers B.W., Emeis J.J., Kooistra T., Trimbos J.B., Moore N.R., Zwinderman K.H., et al. A role for the fibrinolytic system in postsurgical adhesion formation. Fertil Steril 83 (2005) 122-129
24. Chegini N., Kotseos K., Bennett B., Diamond M.P., Holmdahl L., and Burns J. Matrix metalloproteinase (MMP-1) and tissue inhibitor of MMP in peritoneal fluids and sera and correlation with peritoneal adhesions. Fertil Steril 76 (2001) 1207-1211
25. Holmdahl L., Kotseos K., Bergstrom M., Falk P., Ivarsson M.L., and Chegini N. Overproduction of transforming growth factor-beta1 (TGF-beta1) is associated with adhesion formation and peritoneal fibrinolytic impairment. Surgery 129 (2001) 626-632